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We have studied the transcription directed by the promoter of a Xenopus borealis cardiac actin gene fused to a globin reporter sequence after injection 
into X laevis embryos. This promoter is known to be effective specifically in somites of neurula stage embryos, and work on a very similar X laevis 
gene has indicated the importance of an upstream MyoD binding site (E box) in this process. We show that, although in the absence of the MyoD 
site there is a small amount of tissue-specific expression in neurulae, transcription is abundant in the tailbud embryo a few hours later. Thus, 
although the E box is initially essential, other sequences must adopt the same role soon afterwards. 
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1. INTRODUCTION 
The a-cardiac actin gene is one of the first tissue- 
specific genes to be activated in the Xenopus embryo, 
appearing at the late gastrula stage in the regions 
shortly to form the somites [l]. The cloned promoter 
region has been shown to retain its tissue specificity 
when injected as part of a linear DNA molecule into the 
cytoplasm of the fertilized Xenopus embryo [2,3]. This 
is also true for the a3 skeletal actin gene [4,5]. Detailed 
analysis of both promoters has shown that essential 
components are the CArgG boxes, 10 base sequences 
(consensus CC[A/T&GG) that bind members of the 
serum response factor (SRF) family. In the case of car- 
diac actin it is only the proximal CArG box that is 
required [6], but two boxes are needed for the skeletal 
a3 gene [5]. However, the CArG boxes seem to play 
only a permissive role in transcription, and other se- 
quences are needed to activate the gene in muscle. For 
the X laevis cardiac gene, Taylor et al. [7] found that 
a MyoD binding site, located upstream of the distal 
CArG box, was sufficient to produce stage- and tissue- 
specific activaiton of expression. Their experiments 
were conducted on neurula stage embryos. We have 
now extended our original analysis of an almost identi- 
cal X borealis cardiac actin gene [3] to show that the 
MyoD site is either inoperative or redundant at later 
stages. 
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2. MATERIALS AND METHODS 
2.1. Biological materials 
Embryos were obtained, dissected and microinjected at the 2-1~11 
stage as previously described [3]. The DNA for micro-injection (25 
@ml) was linearised with PstI. 
2.2. DNA manipulation 
The cardiac actin clone used was that of X borealis described by 
Wilson et al. [3]. The first EcoRI fragment of this clone contains the 
first exon and its flanking regions (790 bp upstream to 489 bp down- 
stream of the start of transcription). The fragment was digested or 
partially digested with SstI and AccI, appropriate restriction frag- 
ments were subcloned inot Ml3 mp18 and sequenced by the dideoxy 
chain-termination method [8]. 
The 5’ regions, from an AccI site 331 bp upstream of the start of 
transcription (Fig. lA), to a BstNI site in the first, untranslated exon 
of the actin gene, were excised from the cloned EcoRI fragment men- 
tioned above and the ends infilled. The upstream regions of a X laevis 
B-globin gene [9], from an EcoRI site at the insert/vector boundary to 
an NcoI site at the first translated ATG in exon 1, were excised and 
the ends filled in and dephosphorylated. The actin upstream regions 
were then fused into this globin-carrying vector to give an actin/globin 
fusion gene, pAG1, fused in the two first exons (Fig. 1A). 
Further deletions of the actin upstream regions were made by exo- 
nuclease III digestion as follows. pAG1 was digested with EcoRI 
followed by ExoIII (18 U/pg DNA). The reaction was terminated by 
adding 0.1 vol of 10 x Sl nuclease buffer (0.5 M sodium acetate, pH 
4.0, 60 mM ZnSO,). The ends were made blunt by treating with Sl 
nuclease (10 U/pg DNA, 23°C 15 min). The reaction was terminated 
with 0.1 vol. 0.1 M EDTA, 1.5 M sodium acetate and the solution 
extracted with phenol/chloroform. Any remaining overhangs were 
eliminated by infilling with the Klenow fragment of DNA polymerase. 
The constructs were re-circularised in the presence of EcoRI linker. 
2.3. RNA analysis 
The total nucleic acid from 410 whole embryos or dissected em- 
bryo fragments was extracted by a proteinase K/phenol extraction 
procedure [3]. Correct transcripts from the actin/globin fusion genes 
were detected by primer extension from an end-labelled 27 base syn- 
thetic oligonucleotide complementary to residues 13-39 of the first 
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exon of the /I-globin gene. Methods were as described previously [3] 
and the products were analysed on 10% sequencing els. Standard 
Southern blotting methods were used to analyse distribution of the 
injected cloned DNA, using the total nucleic acid extracts described 
above after BumHI digestion 131. The nick-translated cloned plasmid 
was used as a probe. 
3. RESULTS 
We have previously described the transcription of an 
X. borealis cardiac actin/globin fusion gene injected into 
two-cell X. laevis embryos [3]. In this paper we examine 
the transcription of a series of 5’ deletions of this gene 
(the clone differs in that the reporter part of the con- 
struct was previously from mouse /I-globin, but in this 
case it is from X. laevis; see Lakin et al. [5] for similar 
use of this reporter). 
First we sequenced the entire EcoRI fragment which 
encompasses exon 1 of the X. borealis cardiac actin 
gene. The part of this fragment relevant to the experi- 
ments described below is shown in Fig. 1. The X laevis 
and X. borealis sequences are extremely similar as far 
as 410 bp upstream of the start of transcription, but 
thereafter diverge almost completely. Between -320 bp 
and -350 bp the upstream region of the promoter con- 
tains three E boxes, or binding sites for the MyoD 
group of helix-loop-helix transcription factors (consen- 
sus CANNTG). This region is also present in the X. 
laevis cardiac actin gene, a region called by Taylor et al. 
S EA E E 
[7] the “M-region”. At the neurula stage they found it 
to be essential for transcription. The longest clone stud- 
ied here, pAG1, was truncated at an AccI site 331 bp 
upstream of the start of transcription and it contains 
only the proximal E box (Fig. 2). The wild-type gene 
also contains an E box consensus equence at the 3’ end 
of the first exon, but this was destroyed in fusing the 
actin fragment to the globin gene. The clone deleted to 
-258 bp, called PAG~~~~~, lacks all of the E boxes (Fig. 
2). Further downstream are the four CArG boxes, also 
seen in the X. laevis gene. These are progressively re- 
moved in the series of deletions shown in Fig. 2. 
As in previous studies the cloned genes were injected 
into 2-cell embryos and, in order to study transcription 
at the neurula stage (stage 19) the embryos were dis- 
sected into animal, equatorial and vegetal fragments at 
stage 9 (blastula; Fig. 3D), and these fragments were 
incubated until undissected embryos had reached stage 
19. Muscle develops only in the cultured equatorial frac- 
tion. Fig. 3B shows that at this stage the transcription 
of pAG1, the longest construct, was only just detectable 
and, as expected, it was in the equatorial fraction. In the 
pAGl,z, deletion as extremely faint band was visible 
to the eye in the axis fragment. For neither stage were 
there detectable signals in the intact embryos. This is in 
line with the results of Taylor et al. [7] and indicates that 
the incubated embryo fragments are very slightly differ- 
ent from intact embryos, perhaps in timing events. At 
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Fig. 1. Construction of the actin/globin fusion clone. (1) Structure of the X borealis cardiac actin gene in the vector, pEMBL8. The position of 
only four of the exons was determined by sequencing. (2) An EcoRI fragment was subcloned from this and (3) used as a source of an AccI-BsrNI 
fragment. (4) Structure of the X. Zuevis,Qlobin clone [9]. (5) An NcoI-EcoRI fragment of the latter was isolated. (6) It was fused to the AccI-BstNI 
fragment described above. Abbreviations for restriction enzyme cutting sites: A, AccI; B, BstNI; E, EcoRI; N, NcoI. 
42 
Volume 335, number 1 FEBS LETTERS November 1993 
-4299 A6 ACTT tG 
ATCCCTTTCA TAATATTkT A%TCCCAGT 
-369 G TT T 
CCCTCGACAG CCCCCCTGCA CAATTGTGCT 
MyoD 
-309 T 
TGCCTGTGSA AACTATTTC: TTi%TGiG 
-249 
CATGCTTTTT TGGGAAT~C~ TATTTGGCCA 
CArG box4 
-189 T 
A187t CArG box3 
TTTCCATACA TGGGCTAAGG GG;;W;;AGA 
-129 
mCTTCTTT GCTTTTCAAT GGC&AAG 
-69 
~~~T~~~GAG CTCCCACTGA CTCCTCA&T 
G C 
~CAGACAGGG TATAAATTGA 
TA42 TATA 
-9 G - +l 
GCTGGAGAiG CCAALAGGCA 
T 
GCACCTGTCT ACTCCATATG 
MyoD tA331 MyoD 
-CG 
GTTTTTTTTT TTGTCACCCA 
TCCCTfGTAG TGCTCCCCCC 
GGATGCk 
CAGACCCCTG 
ACCTCCATAC 
CCCTGCCC'& CCCIjTCACCT ACTUATTAA 
TA151 TA142 CArG box2 
GCCTGCCTTT 
CAGCTCAGTC 
CC~AAGCCAG CACCCAGCCA ATTCAATCAC AGCAACCAGC TCTCCTGTGC TAACCAGGTG 
=s Exonl 
+52 
AGTACTCTFT GGGACATAC; GGTTGGTTCT TTGCTGCTGG ACGGATFTCT GCCATTTCAC 
Fig. 2. Sequence of part of the ZcoRI fragment shown in Fig. l(2). The 5’ start points of all the clones is shown below the sequence (4331442). 
CArG boxes and MyoD binding sites are also shown below the sequence. The most downstream MyoDl site is within the BsrNI site used for fusion 
to globin and was destroyed in this process. Base differences with the X. luevis cardiac actin gene [2] are marked above the sequence; extra bases 
in X. Iaevis are marked in lower case, and are in the space after the residue marked; extra bases in X. borealis are marked with a hyphen. 
the later tailbud tadpole stage, dissections were per- 
formed at the actual stage tested (Fig. 3C). A strong 
tissue-specific signal was obtained with pAGl and this 
was seen only in the muscle-containing axial fragment. 
Since the injected DNA was found in all fractions of the 
embryo tested, the reason for an absence of expression 
in non-muscle-containing regions was not that the DNA 
was unevenly distributed (Fig. 4). This Southern blot 
expeirment shows variability of levels of the injected 
cloned sequence, but there is sometimes trong expres- 
sion from axis fragments where hybridisation to the 
injected DNA level is relatively weak (e.g. pAG,&, 
and absent when it is strong (e.g. pAGdls,). 
Although PAGI,,~~ lacks all E boxes, the signal it 
generated was not reproducibly different from that of 
pAGl (Fig. 3A). There were detectable, but markedly 
reduced signals in pAG1 d18r-pAGldlS1; these were 10% 
or less of those from pAG1. These differences did not 
simply reflect the level to which DNA had replicated in 
the embryo (Fig. 4). Fig. 2 shows that PAG~,,~~ con- 
tains all four CArG boxes, but pAGl,,rs7 lacks CArG 
box4; pAGl,,,, and pAG1,rS, in addition lack CArG 
box3. Greater deletions did not give detectable tran- 
scription and it is interesting that PAG~,,~*, which is the 
cut-off point for tr~s~~ption, is only slightly shorter 
than pAGldIsl and retains CArG box3. 
These results therefore indicate that, while a cardiac 
promoter clone lacking a MyoDl binding E box has 
little or no transcriptional activity in the neurula, a few 
hours later it is highly active in the muscle-forming 
region in the tailbud tadpole. 
4. DISCUSSION 
The restriction of promoter activity to particular 
types of cells usually depends on combinations of sites 
which bind ubiquitous transcription factors and those 
that bind tissue-specific factors. In the case of striated 
mu~le-s~cific a-a&in genes the important ubiquitous 
factors are the CArG boxes, or ~~rn-respond ele- 
ments, which bind members of the serum response fac- 
tor (SRF) family [IO]. For example in the case of the _X. 
laevis cardiac actin gene, at least one CArG box is re- 
quired for the function of cloned genes injected into the 
embryo [6] and Xenopus embryos contain several spe- 
cies of SRF [9,11]. A X borealis skeletal actin gene 
seems to require at least two CArG boxes for activity 
in the embryos [5]. However, while SRF binding is nec- 
essary, it is not sufficient for actin expression in the 
muscles of the embryo, and one class of transcription 
factor shown to be capable of providing the necessary 
tissue-specific omponent are the muscle-specific helix- 
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laap-helix-containing proteins, of which MyoDl was 
the prototype. This was identified by virtue of its ability 
NY switch on the terminal myotube phenotype in C3H 
10Ty2 fibrobiasts f12]. Other members of the family 
include myogenin, Myf-5, and MRF4, also called her- 
culin md myf-6 f13-17j. 
pression of MyoD will turn on the cardiac actin gene in 
tissues where it is not normally expreesed, but the fate 
of these cells is not diverted to muscle [24,253. However, 
Taylor et al. [73 have argued that the E boxes are essen- 
tial for expression of the cloned X. Iaevis c;isdiac a-act& 
gene. Their assays 3vere performed on tissue fragment5 
fram neuruiae and in&&d a member of internal dele- 
tiorrs of the prumoter. Om= results agree with theirs in 
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Fig. 4. Southern blot analyses of injected DNA in samples also analysed for actin RNA. Aliquots of the total nucleic acid extracts analysed by 
pruner extension in Fig. 3A, were digested with BumHI, which produces two DNA fragments from the replicated linear concatenates of injected 
DNA found in embryos injected with linear actin gene constructs. The DNA was analysed by agarose gel electrophoresis, Southern blotted and 
probed with nick-translated pAG1. 
that removing all three E boxes in the promoter gave 
indetectable transcription in the muscle-forming region 
of the neurula. There was also very little transcription 
from a promoter containing a single E box, as opposed 
to the three in the wild-type sequence. However, at the 
tailbud tadpole stage, only a few hours later, both dele- 
tion clones were highly active in the appropriate region. 
Thus in the tailbud, embryo sequences other than the 
E box sequences must be capable of directing appropri- 
ate expression of the gene. In the intact gene there are 
therefore likely to be at least two regions separately 
controlling the gene; indeed, functional redundancy in 
the promoter of a Xenopus a3 skeletal actin gene has 
been noted previously [5]. It is not clear what region has 
taken over control of the gene in the absence of the E 
box sites. The data in Fig. 3 suggest that there is an 
important sequence between - 151 and -142. At this 
point there is the same binding sequence for EMF-1, 
also called C/EBP, as was reported in the al -antitrypsin 
gene [26]. However, the significance of this is unclear 
since C/EBP is not expressed in skeletal muscle, at least 
in mammals [27]. 
The fact that a gene should not necessarily depend on 
the MyoD family for transcription in skeletal muscle is 
not unprecedented, for example, the ,&myosin gene en- 
hancer does not require E boxes [28]. Further, gene 
knock-out experiments indicate that MyoD and myf-5 
are individually redundant for the formation of most 
muscles and some muscles can form in the absence of 
myogenin [29-321. However, it is not yet clear whether 
skeletal muscle can ever form in the collective absence 
of the whole family. Lastly some, at least, of the family 
can be expressed in a cell without activating many mus- 
cle-specific genes. This was shown in the electric organ 
of Torpedo where the MyoD, myogenin and myf-5 lev- 
els are similar to those in skeletal muscle, but the proper 
differentiated muscle phenotype is not expressed [33]. 
What we show here is that for the cardiac actin gene 
there is an early developmental stage when its E box is 
essential, but a few hours later it is not. Whether this is 
true for other genes in these developing somites remains 
to be seen. 
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